Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
病原微生物（Pathogenic microorganism）
- Molecular classification
- Other
01
Overview
病原微生物是指能够导致人类、动物或植物发病的各种微生物和类生物的总称，主要包括细菌、病毒、真菌、原生动物、类病毒、朊病毒等[1][3][8]。这些微生物可以通过多种机制引起宿主感染和疾病，例如生产毒素、破坏细胞结构、劫持营养、逃避宿主免疫反应等[1][3][8]。临床上主要针对具体的病原微生物采用抗生素、抗病毒药、抗真菌药或免疫治疗等手段进行治疗。但“病原微生物”本身并不是严格意义上的“分子靶点”，而是一个高度宏观、生物分类意义上的术语。实际药物开发和靶点研究需细分到具体微生物及其分子（如 HIV 逆转录酶、革兰氏阳性细菌细胞壁合成酶等）[1][3][8]。
- Other names
- 病原体致病原传染原感染原pathogeninfectious agentgerm
02
Biological functions
可引起宿主发病感染毒性侵袭性免疫抑制
03
Disease associations
感染炎症其他与病原微生物相关的疾病
Beyond the preview
Go deeper on 病原微生物（Pathogenic microorganism）.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 病原微生物（Pathogenic microorganism）.